RUBIUS THERAPEUTICS
Rubius Therapeutics is creating RCTs™ as a new class of medicines. Leading applications include programs in cancer, enzyme deficiency diseases and the induction of tolerance to treat autoimmune disease. The company was conceived and launched by Flagship VentureLabs®, the innovation foundry where a team of scientific entrepreneurs systematically evolve enterprising ideas based upon previously undiscovered areas of science into real-world inventions and ventures.
RUBIUS THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.rubiustx.com
Total Employee:
101+
Status:
Active
Contact:
(617)218-1606
Email Addresses:
[email protected]
Total Funding:
445 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes develops technologies and raw materials for the nuclear medicine market.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Flagship Pioneering
Flagship Pioneering investment in Series C - Rubius Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Rubius Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series A - Rubius Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-30 | Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer |
Official Site Inspections
http://www.rubiustx.com Semrush global rank: 3.46 M Semrush visits lastest month: 4.41 K
- Host name: 172.67.143.14
- IP address: 172.67.143.14
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rubius Therapeutics"
Rubius Therapeutics - Crunchbase Company Profile
Organization. Rubius Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Rubius Therapeutics - LinkedIn
Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORMâ„¢ was designed to genetically engineer and culture Red Cell ...See details»
Rubius Therapeutics Inc (RUBY) Profile - The Globe and Mail
See the company profile for Rubius Therapeutics Inc (RUBY) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Rubius Therapeutics: Revenue, Competitors, Alternatives
We are planning to file additional INDs in rare diseases, cancer and autoimmune diseases in 2019, 2020 and beyond. The company, a 2017 Fierce 15 award winner, was founded in 2013, …See details»
Rubius Therapeutics (USA) Funding: $445M - Medical Startups
Mar 11, 2025 Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry …See details»
Rubius Therapeutics, Inc. - Cruelty Free Investing
Company Website: https://www.rubiustx.com Contact: [email protected] ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Rubius Therapeutics Company Profile - Craft
Jul 18, 2024 Rubius Therapeutics is developing Red-Cell Therapeuticsâ„¢ (RCTsâ„¢) as a new class of medicines to address a wide array of indications, with leading applications in cancer, …See details»
Rubius Therapeutics
Feb 25, 2025 https://www.rubiustx.com Dive deeper into fresh insights across Business , Industry Leaders and Influencers , Organizations , Education , and Investors for a …See details»
Rubius Therapeutics - Employees, Contact info, Overview - Wiza
View info about Rubius Therapeutics (rubiustx.com). Rubius Therapeutics is a company located in Cambridge, Massachusetts, United States. Find employees, official website, emails, phone …See details»
Company Rubius Therapeutics, Inc. Deutsche Boerse AG
Mar 23, 2003 Rubius Therapeutics, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG ...See details»
Rubius Therapeutics Company Overview, Contact Details
Mar 16, 2021 Rubius Therapeutics. Biotechnology Research Massachusetts, United States 201-500 Employees. Rubius Therapeutics is a biopharmaceutical company pioneering a new era …See details»
Rubius Therapeutics - Golden
What is Rubius Therapeutics? Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies that is headquartered in Cambridge, Massachusetts …See details»
Company Rubius Therapeutics - MarketScreener.com
Rubius Therapeutics: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | OTC Markets: RUBY | OTC ...See details»
Rubius Therapeutics Careers and Employment | Indeed.com
Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeuticsâ„¢. Our proprietary RED PLATFORM® was designed …See details»
Rubius Therapeutics Announces Process to Explore Strategic …
Nov 2, 2022 Dannielle Appelhans to Become President and Chief Executive Officer Pablo J. Cagnoni, M.D., Appointed Chair of the Board of Directors CAMBRIDGE, Mass., Nov. 02, 2022 …See details»
Rubius Therapeutics Announces Strategic Update - GlobeNewswire
Sep 13, 2022 As a result, we have decided to discontinue our ongoing clinical trials of RTX-240 and RTX-224 for the treatment of advanced solid tumors and restructure the organization to …See details»
Rubius Therapeutics Appoints Dannielle Appelhans as Chief
CAMBRIDGE Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is...See details»
Scientist/Sr. Scientist, Autoimmunity @ Rubis Therapeutics
Mar 16, 2020 Scientist/Sr. Scientist, Autoimmunity HIRING MANAGER Salam Shaaban DEPARTMENT Autoimmunity LOCATION Cambridge. Rubius Therapeutics is a clinical-stage …See details»
Rubius Therapeutics Careers - Levels.fyi
Rubius Therapeutics is a clinical-stage biopharmaceutical company that develops red cell therapeutics for severe diseases. They are developing treatments for solid tumors, cancers, …See details»
Rubius Therapeutics to Announce Fourth Quarter and Full Year …
Feb 9, 2021 Contacts:Elhan Webb, CFAVice President, Investor [email protected]: Marissa HanifyDirector, Corporate …See details»